Entourage Health Corp. today announced its financial results for the three months and six months ending June 30, 2024.

Entourage Health Corp. announced today that the Company's second quarter 2024 financial results will be released after market close on Monday, August 26, 2024.

Entourage Health Corp. is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held virtually on June 12, 2024.

Entourage Health Corp. today announced its financial results for the three months ended March 31, 2024.

Entourage Health Corp. announced today it will file its first quarter 2024 financial statements and management’s discussion and analysis after market on Monday, May 27, 2024.

Entourage Health Corp. today unveiled the expansion of its product portfolio. Entourage also announced the expansion of Dime Bag branded pre-rolls into Alberta, introducing Diesel and Tropical Pocket Puffs.

Entourage Health Corp. announced today its financial results for the fiscal year that ended December 31, 2023.

Entourage Health Corp. announced today that it will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended December 31, 2023, after market close on April 29, 2024.

Entourage Health Corp. Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, will step down to pursue other career opportunities, effective December 18, 2023.

Entourage Health Corp. announced today its financial results for the three and nine months ended September 30, 2023.

Entourage Health Corp. announced today it will file its third quarter 2023 financial statements and management’s discussion and analysis after-market on Monday, November 27, 2023.

Entourage Health Corp. announced it has entered into an amended supply agreement with HEXO Corp..

Entourage Health Corp. announced today its financial results for the three months and six ended June 30, 2023.

Entourage unveils a wave of nostalgic Dime Bag® branded pre-roll offerings, now available in Ontario. Additionally, the Company introduces Syndicate-branded cannabis products, featuring exclusive limited-edition offerings from micro-cultivators now available across Ontario.

Entourage announced today it will file its second quarter 2023 financial statements and management’s discussion and analysis after market on Tuesday, August 29, 2023.

Entourage announced today the successful sale, execution and fulfilment of its first international order of 100kg of bulk medical cannabis to Australia.

Entourage announced today that the Company has partially repaid its senior secured credit facility with Bank of Montreal from the net proceeds of the sale of its Strathroy facility and cash.

Entourage is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held virtually in Toronto, Ontario on June 14, 2023.

Entourage announced today its financial results for the three months ended March 31, 2023.

Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.